cefepime Vials, injection 0.5 g, 1 g
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
PICS
Manufacturer #540
This global pharmaceutical company boasts an impressive 80 years of experience in developing and delivering a diverse range of products. Their portfolio spans prescription medications, over-the-counter drugs, herbal teas, and penicillin production. They hold over 1643 marketing authorizations for more than 400 products distributed across 50 countries. Key therapy areas include those addressing respiratory health, pain management, and cardiovascular conditions. Their manufacturing facilities are equipped to produce various dosage forms including effervescent & oral liquids, topical preparations, softgels, and oral solids. The company prioritizes quality with GMP certifications, reflecting their commitment to safety and efficacy.
Manufacturer usually replies in 18 days
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.